Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 673.50
Bid: 674.50
Ask: 675.00
Change: -2.00 (-0.30%)
Spread: 0.50 (0.074%)
Open: 676.00
High: 676.00
Low: 669.50
Prev. Close: 675.50
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

20 Apr 2012 07:00

20 April 2012 - Tate & Lyle PLC

SALE OF CITRIC ACID JOINT VENTURE

Tate & Lyle announces that it has reached agreement to sell its 50% share in Sucromiles, its Colombian citric acid joint venture, to its long-standing partner in this business, Organización Ardila Lülle, for total cash consideration of US $31.5 million (£19.6*m). Following completion of the sale, which is conditional upon Colombian competition authority approval, Tate & Lyle will continue to distribute citric acid products from Sucromiles outside the Colombian market.

END

For more information contact Tate & Lyle PLC:

Mathew Wootton, Group VP, Investor and Media Relations
Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7500 100 320
Andrew Lorenz (FTI Consulting), Media Relations
Tel: +44 (0) 20 7269 7113 or Mobile: +44 (0) 7775 641 807

About Tate & Lyle:

Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, operating from over 30 production facilities around the world.

Tate & Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.

Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2011, Tate & Lyle sales totalled £2.7 billion. http://www.tateandlyle.com.

SPLENDA® is a trademark of McNeil Nutritionals, LLC.

About Organización Ardila Lülle:

Organización Ardila Lülle is a leading Colombian Industrial Group in the Beverage, Agro industrial, Radio, Television, and Packaging sectors among others.

*£/US$ exchange rate 1.61

Copyright Business Wire 2012

Date   Source Headline
5th Aug 20193:00 pmRNSIssue of Debt
1st Aug 20192:00 pmRNSTotal Voting Rights
25th Jul 201912:58 pmRNSResult of AGM
18th Jul 20193:00 pmRNSDirector/PDMR Shareholding
17th Jul 20197:02 amRNSChange to Executive Committee
1st Jul 201912:40 pmRNSBlock listing Interim Review
1st Jul 201912:38 pmRNSTotal Voting Rights
1st Jul 201912:00 pmRNSDirector/PDMR Shareholding
10th Jun 201911:30 amRNSAnnual Financial Report
5th Jun 20199:52 amRNSHolding(s) in Company
5th Jun 20199:34 amRNSDirector/PDMR Shareholding
3rd Jun 201910:42 amRNSTotal Voting Rights
29th May 20194:00 pmRNSDirector/PDMR Shareholding
28th May 20194:12 pmRNSDirector/PDMR Shareholding
23rd May 20197:00 amRNSFinal Results
9th May 201911:00 amRNSDirectorate Change
1st May 201910:00 amRNSTotal Voting Rights
1st Apr 20194:17 pmBUSTotal Voting Rights
1st Apr 20193:45 pmBUSHolding(s) in Company
1st Mar 201911:21 amBUSTotal Voting Rights
27th Feb 20191:00 pmBUSHolding(s) in Company
7th Feb 20197:00 amBUSTrading Statement
1st Feb 201911:40 amBUSTotal Voting Rights
3rd Jan 20192:00 pmBUSDirector/PDMR Shareholding
2nd Jan 20193:53 pmBUSBlock listing Interim Review
6th Dec 201811:32 amBUSDirector/PDMR Shareholding
5th Dec 20182:22 pmBUSDirector/PDMR Shareholding
3rd Dec 20183:34 pmBUSTotal Voting Rights
19th Nov 20187:00 amBUSDirectorate change
8th Nov 20187:00 amBUSHalf-year Report
1st Nov 201812:20 pmBUSTotal Voting Rights
5th Oct 20182:05 pmBUSDirector/PDMR Shareholding
1st Oct 20182:25 pmBUSTotal Voting Rights
21st Sep 201811:43 amBUSDirector/PDMR Shareholding
10th Jul 201811:21 amBUSDirector/PDMR Shareholding
10th Jul 201810:50 amBUSHolding(s) in Company
2nd Jul 20183:42 pmBUSTotal Voting Rights
2nd Jul 20183:11 pmBUSBlock listing Interim Review
28th Jun 20185:37 pmBUSDirector/PDMR Shareholding
21st Jun 201812:34 pmBUSAnnual Financial Report
14th Jun 20185:34 pmBUSDirector/PDMR Shareholding
6th Jun 20186:21 pmBUSDirector/PDMR Shareholding
1st Jun 201812:44 pmBUSTotal Voting Rights
29th May 20185:54 pmBUSDirector/PDMR Shareholding
24th May 20187:00 amBUSFinal Results
1st May 20181:00 pmBUSTotal Voting Rights
18th Apr 201812:27 pmBUSDirector/PDMR Shareholding
17th Apr 20187:00 amBUSImran Nawaz Appointed Chief Financial Officer of Tate & Lyle PLC
13th Apr 20181:48 pmBUSDirector Declaration
5th Apr 20184:31 pmBUSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.